Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes
- PMID: 11860702
- DOI: 10.1089/10430340252792486
Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes
Abstract
One potential strategy for gene therapy of Parkinson's disease (PD) is the local production of dopamine (DA) in the striatum induced by restoring DA-synthesizing enzymes. In addition to tyrosine hydroxylase (TH) and aromatic-L-amino-acid decarboxylase (AADC), GTP cyclohydrolase I (GCH) is necessary for efficient DA production. Using adeno-associated virus (AAV) vectors, we previously demonstrated that expression of these three enzymes in the striatum resulted in long-term behavioral recovery in rat models of PD. We here extend the preclinical exploration to primate models of PD. Mixtures of three separate AAV vectors expressing TH, AADC, and GCH, respectively, were stereotaxically injected into the unilateral putamen of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys. Coexpression of the enzymes in the unilateral putamen resulted in remarkable improvement in manual dexterity on the contralateral to the AAV-TH/-AADC/-GCH-injected side. Behavioral recovery persisted during the observation period (four monkeys: 48 days, 65 days, 50 days, and >10 months, each). TH-immunoreactive (TH-IR), AADC-IR, and GCH-IR cells were present in a large region of the putamen. Microdialysis demonstrated that concentrations of DA in the AAV-TH/-AADC/-GCH-injected putamen were increased compared with the control side. Our results show that AAV vectors efficiently introduce DA-synthesizing enzyme genes into the striatum of primates with restoration of motor functions. This triple transduction method may offer a potential therapeutic strategy for PD.
Similar articles
-
Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease.Hum Gene Ther. 2000 Jul 20;11(11):1509-19. doi: 10.1089/10430340050083243. Hum Gene Ther. 2000. PMID: 10945765
-
Persistent Expression of Dopamine-Synthesizing Enzymes 15 Years After Gene Transfer in a Primate Model of Parkinson's Disease.Hum Gene Ther Clin Dev. 2017 Jun;28(2):74-79. doi: 10.1089/humc.2017.010. Epub 2017 Mar 9. Hum Gene Ther Clin Dev. 2017. PMID: 28279081
-
Adeno-associated virus vector-mediated triple gene transfer of dopamine synthetic enzymes.Chin Med J (Engl). 2001 Dec;114(12):1276-9. Chin Med J (Engl). 2001. PMID: 11793852
-
[Gene therapy for Parkinson's disease: studies in animal models].Rinsho Shinkeigaku. 2001 Dec;41(12):1157-9. Rinsho Shinkeigaku. 2001. PMID: 12235825 Review. Japanese.
-
Recent progress in gene therapy for Parkinson's disease.Curr Mol Med. 2012 Dec;12(10):1311-8. doi: 10.2174/156652412803833580. Curr Mol Med. 2012. PMID: 22834832 Review.
Cited by
-
The use of nonhuman primate models to understand processes in Parkinson's disease.J Neural Transm (Vienna). 2018 Mar;125(3):325-335. doi: 10.1007/s00702-017-1715-x. Epub 2017 Mar 29. J Neural Transm (Vienna). 2018. PMID: 28357564 Review.
-
Tetrahydrobioterin (BH4) Pathway: From Metabolism to Neuropsychiatry.Curr Neuropharmacol. 2021;19(5):591-609. doi: 10.2174/1570159X18666200729103529. Curr Neuropharmacol. 2021. PMID: 32744952 Free PMC article. Review.
-
A phase I study of aromatic L-amino acid decarboxylase gene therapy for Parkinson's disease.Mol Ther. 2010 Sep;18(9):1731-5. doi: 10.1038/mt.2010.135. Epub 2010 Jul 6. Mol Ther. 2010. PMID: 20606642 Free PMC article. Clinical Trial.
-
Potential cellular and regenerative approaches for the treatment of Parkinson's disease.Neuropsychiatr Dis Treat. 2008 Oct;4(5):835-45. doi: 10.2147/ndt.s2013. Neuropsychiatr Dis Treat. 2008. PMID: 19183776 Free PMC article.
-
Catecholamines and Parkinson's disease: tyrosine hydroxylase (TH) over tetrahydrobiopterin (BH4) and GTP cyclohydrolase I (GCH1) to cytokines, neuromelanin, and gene therapy: a historical overview.J Neural Transm (Vienna). 2024 Jun;131(6):617-630. doi: 10.1007/s00702-023-02673-y. Epub 2023 Aug 28. J Neural Transm (Vienna). 2024. PMID: 37638996 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical